1. Wiseman BS. et al "Stromal effects on mammary gland development and breast cancer" Science. 2002 May 10;296(5570):1046-9
2. Nikhil K. et al "Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ" PLoS One. 2014 Aug 13;9(8):e104592
3. Wiseman BS. et al "Stromal effects on mammary gland development and breast cancer" Science. 2002 May 10;296(5570):1046-9
4. Sundar SN. et al "Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells" Carcinogenesis. 2008 Dec;29(12):2252-8
5. Whelan SA. et al "Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid" J Proteome Res. 2012 Oct 5;11(10):5034-45
6. Manavathi B. et al "Derailed estrogen signaling and breast cancer: an authentic couple" Endocr Rev. 2013 Feb;34(1):1-32
7. Wojcinski S. et al "The biology of malignant breast tumors has an impact on the presentation in ultrasound: an analysis of 315 cases" BMC Womens Health. 2013 Nov 19;13:47
8. Donepudi MS. et al "Breast cancer statistics and markers" J Cancer Res Ther. 2014 Jul-Sep;10(3):506-11
9. Bodai BI. et al "Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations" Perm J. 2015 Spring;19(2):48-79
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.